Literature DB >> 2987681

Characterization of pp60src phosphorylation in vitro in Rous sarcoma virus-transformed cell membranes.

M D Resh, R L Erikson.   

Abstract

Phosphorylation of the src gene product pp60v-src was studied in plasma membrane fractions prepared from Rous sarcoma virus-transformed vole cells. Upon addition of [gamma-32P]ATP to isolated membrane vesicles, phosphate was incorporated into a 60,000-dalton polypeptide identified as pp60v-src. In the presence of vanadate, pp60v-src phosphorylation was stimulated ca. 30-fold. At low concentrations of ATP (1 microM), this reaction occurred almost exclusively on the carboxy-terminal 26,000-dalton region of pp60v-src. However, at higher ATP concentrations (100 microM), additional sites of phosphorylation were evident in the amino-terminal 34,000-dalton region. Kinetic analyses, performed under conditions in which ATP hydrolysis was minimal, revealed that the phosphorylation reaction at the carboxy terminus exhibited a higher Vmax and a lower Km for ATP than those occurring at the amino terminus. In addition, the amino-terminal region of pp60v-src was more rapidly dephosphorylated than the carboxy-terminal region. These results indicate that interaction of pp60v-src with the plasma membrane may limit the extent of amino-terminal phosphorylation by lowering the rate of the reaction and the affinity for the substrate while increasing its susceptibility to phosphoprotein phosphatases. We suggest that the use of transformed-cell membrane preparations provides a model system for studying the possible regulatory roles of phosphorylation and dephosphorylation on pp60v-src function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987681      PMCID: PMC366805          DOI: 10.1128/mcb.5.5.916-922.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Physical modification of purified Rous sarcoma virus pp60v-src protein after incubation with ATP/Mg2+.

Authors:  M S Collett; S K Wells; A F Purchio
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

2.  Development of anti-pp60src serum with antigen produced in Escherichia coli.

Authors:  T M Gilmer; R L Erikson
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

3.  Transit of pp60v-src to the plasma membrane.

Authors:  S A Courtneidge; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

4.  Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate.

Authors:  G Swarup; S Cohen; D L Garbers
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

5.  Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation.

Authors:  F R Cross; H Hanafusa
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

6.  Specific proteolytic fragmentation of p60v-src in transformed cell lysates.

Authors:  S K Wells; M S Collett
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

7.  Changes in amino-terminal sequences of pp60src lead to decreased membrane association and decreased in vivo tumorigenicity.

Authors:  J G Krueger; E A Garber; A R Goldberg; H Hanafusa
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

8.  Temperature-sensitive membrane association of pp60src in tsNY68-infected cells correlates with increased tyrosine phosphorylation of membrane-associated proteins.

Authors:  E A Garber; J G Krueger; H Hanafusa; A R Goldberg
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

9.  Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src.

Authors:  M A Snyder; J M Bishop; W W Colby; A D Levinson
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

10.  Characterization of the Rous sarcoma virus transforming gene product.

Authors:  Y Graziani; E Erikson; R L Erikson
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

View more
  7 in total

1.  Inhibition of the tyrosine kinase activity of v-src, v-fgr, and v-yes gene products by a monoclonal antibody which binds both amino and carboxy peptide fragments of pp60v-src.

Authors:  D J McCarley; J T Parsons; D C Benjamin; S J Parsons
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

2.  In vivo effect of sodium orthovanadate on pp60c-src kinase.

Authors:  J W Ryder; J A Gordon
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

3.  Development and characterization of antisera specific for amino- and carboxy-terminal regions of pp60src.

Authors:  M D Resh; R L Erikson
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

4.  The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.

Authors:  S H Cheng; H Piwnica-Worms; R W Harvey; T M Roberts; A E Smith
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

5.  Platelet-derived growth factor induces multisite phosphorylation of pp60c-src and increases its protein-tyrosine kinase activity.

Authors:  K L Gould; T Hunter
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

6.  Reconstitution of the Rous sarcoma virus transforming protein pp60v-src into phospholipid vesicles.

Authors:  M D Resh
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

7.  Enzymatic activation of Fujinami sarcoma virus gag-fps transforming proteins by autophosphorylation at tyrosine.

Authors:  K Meckling-Hansen; R Nelson; P Branton; T Pawson
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.